These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17958283)

  • 1. 2nd-generation HIV surveillance and injecting drug use: uncovering the epidemiological ice-berg.
    Reintjes R; Wiessing L
    Int J Public Health; 2007; 52(3):166-72. PubMed ID: 17958283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping HIV-related behavioural surveillance among injecting drug users in Europe, 2008.
    Hope V; Jeannin A; Spencer B; Gervasoni JP; van de Laar MJ; Dubois-Arber F;
    Euro Surveill; 2011 Sep; 16(36):. PubMed ID: 21924119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010.
    Wiessing L; Likatavicius G; Hedrich D; Guarita B; van de Laar MJ; Vicente J
    Euro Surveill; 2011 Dec; 16(48):. PubMed ID: 22172300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and AIDS in Bangladesh.
    Azim T; Khan SI; Haseen F; Huq NL; Henning L; Pervez MM; Chowdhury ME; Sarafian I
    J Health Popul Nutr; 2008 Sep; 26(3):311-24. PubMed ID: 18831227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
    Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
    Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/AIDS prevalence in the Southern Caucasus.
    Kvitsinadze L; Tvildiani D; Pkhakadze G
    Georgian Med News; 2010 Dec; (189):26-36. PubMed ID: 21252406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing surveillance for HIV transmission and risk behaviours among high-risk groups in a central London health district.
    Nardone A; Mercey D; Johnson AM; McCarthy M
    J Public Health Med; 1999 Jun; 21(2):208-14. PubMed ID: 10432252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising HIV infection rates in Ho Chi Minh City herald emerging AIDS epidemic in Vietnam.
    Lindan CP; Lieu TX; Giang LT; Lap VD; Thuc NV; Thinh T; Lurie P; Mandel JS
    AIDS; 1997 Sep; 11 Suppl 1():S5-13. PubMed ID: 9376101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV epidemic associated with injecting drug use in Europe: geographic and time trends.
    Hamers FF; Batter V; Downs AM; Alix J; Cazein F; Brunet JB
    AIDS; 1997 Sep; 11(11):1365-74. PubMed ID: 9302447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk behaviors, HIV seropositivity, and tuberculosis infection in injecting drug users who operate shooting galleries in Puerto Rico.
    Robles RR; Marrero CA; Reyes JC; Colón HM; Matos TD; Finlinson HA; Muñoz A; Meléndez M; Sahai H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(5):477-83. PubMed ID: 9580534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and knowledge of sexual transmitted infections, drug abuse, and AIDS among male inmates in a Taiwan prison.
    Feng MC; Feng JY; Chen YH; Chang PY; Lu PL
    Kaohsiung J Med Sci; 2012 Dec; 28(12):660-6. PubMed ID: 23217358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME
    Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.